Thursday, February 9, 2012

Subscribe to the IP Headline RSS feed | Subscribe to the IP Headline feed via Email

Drug Industry Anticipates More Work Ahead Following Health Care Reform Bill’s Final Passage

While praising individual provisions of the final health care overhaul bill, pharmaceutical industry groups said that the legislation the House approved March 21 is an imperfect measure, and they will continue to work on issues such as pay-for-delay patent settlements and generic competition with biologic drugs.

cforms contact form by delicious:days

Comments

Please feel free to comment on this article...
You can obtain a picture to go with your comment at gravatar!